abediterol   Click here for help

GtoPdb Ligand ID: 9326

Synonyms: LAS-100977
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Abediterol (AS100977) is an investigational long-acting beta(β)-agonist (LABA) [1], in development as a once-daily treatment for asthma [2] and potentially COPD. Currently available LABAs approved for use by asthmatic patients include salmeterol, formoterol and olodaterol.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 4
Rotatable bonds 13
Topological polar surface area 94.58
Molecular weight 460.22
XLogP 4.54
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=c1ccc2c([nH]1)c(O)ccc2C(CNCCCCCCOCC(c1ccccc1)(F)F)O
Isomeric SMILES O=c1ccc2c([nH]1)c(O)ccc2[C@H](CNCCCCCCOCC(c1ccccc1)(F)F)O
InChI InChI=1S/C25H30F2N2O4/c26-25(27,18-8-4-3-5-9-18)17-33-15-7-2-1-6-14-28-16-22(31)19-10-12-21(30)24-20(19)11-13-23(32)29-24/h3-5,8-13,22,28,30-31H,1-2,6-7,14-17H2,(H,29,32)/t22-/m0/s1
InChI Key SFYAXIFVXBKRPK-QFIPXVFZSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Aparici M, Gómez-Angelats M, Vilella D, Otal R, Carcasona C, Viñals M, Ramos I, Gavaldà A, De Alba J, Gras J et al.. (2012)
Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models.
J Pharmacol Exp Ther, 342 (2): 497-509. [PMID:22588259]
2. Beier J, Fuhr R, Massana E, Jiménez E, Seoane B, de Miquel G, Ruiz S. (2014)
Abediterol (LAS100977), a novel long-acting β2-agonist: efficacy, safety and tolerability in persistent asthma.
Respir Med, 108 (10): 1424-9. [PMID:25256258]